您的浏览器禁用了JavaScript(一种计算机语言,用以实现您与网页的交互),请解除该禁用,或者联系我们。[港股财报]:创美药业2022年报 - 发现报告
当前位置:首页/财报/招股书/报告详情/

创美药业2022年报

2023-04-28港股财报变***
创美药业2022年报

地址:中國廣東省汕頭市龍湖區嵩山北路235號電話:86-754-88109272郵箱:ir@charmacy.cnAddress: No. 235 Song Shan North Road, Longhu District, Shantou City, Guangdong Province, the PRCTel: 86-754 88109272Email: ir@charmacy.cn(於中華人民共和國註冊成立之股份有限公司)(A joint stock limited liability company established in the People’s Republic of China)2022年報ANNUAL REPORT股份代號 Stock Code:2289.HK 2022 年報 ANNUAL REPORT -001- 年度报告 ANNUAL REPORT 2022 創美藥業股份有限公司(股份代號:2289.HK)主營醫藥分銷業務,主要向下游分銷商和零售終端分銷西藥、中成藥、保健品等產品,同時也開展第三方物流服務,並提供醫藥產品諮詢服務。公司創立於2000年,經過23年的快速發展,已成長為華南地區領先的醫藥分銷商之一。公司堅持「深耕廣東,輻射周邊」的發展戰略,立足於汕頭,在廣州、珠海、惠州、佛山及深圳成立子公司,並擁有四個現代化醫藥物流中心,專業的營銷服務團隊以及運輸服務團隊,對非招標市場實行「半徑10公里內一日三配、50公里內一日兩配、250公里內一日一配」的高效配送機制。公司具有現代化信息系統,涵蓋整個醫藥分銷供應鏈,包括採購、銷售、倉儲、運輸及交付等。公司同時運營自建的B2B電子商務平臺:「創美e藥」,供客戶線上下單、查詢及支付等。公司於2021年全國批發企業主營業務收入前100位排序前40。公司於廣東省醫藥流通企業排名第6位。 Charmacy Pharmaceutical Co., Ltd. (stock code: 2289.HK) is principally engaged in the pharmaceutical distribution business. It mainly distributes western medicine, Chinese patent medicine and healthcare products to downstream distributors and retail terminals, while conducting dealings in the third-party logistics business of medicines and providing pharmaceutical products related consulting services. Founded in 2000, over the past 23 years of rapid development, it has become one of the leading pharmaceutical distributors in the Southern China region. The Company adheres to the development strategy of “Intensive Engagement in Guangdong Province and Extensive Coverage across Surrounding Areas”, based in Shantou, it has established subsidiaries in Guangzhou, Zhuhai, Huizhou, Foshan and Shenzhen, and has four modern pharmaceutical logistics centers., all equipped with Professional marketing service team, professional transportation teams, and has a highly efficient delivery mechanism of delivering pharmaceutical products three times per day for customers within a radius of 10 kilometers, twice per day for customers within a radius of 50 kilometers and once per day for those within a radius of 250 kilometers. In addition, the Company has a modern information system that covers the entire supply chain for pharmaceutical distribution, including procurement, sales, warehousing, transportation and delivery. Apart from that, the Company operates its own B2B e-commerce platform “Charmacy e-Medicine” (創美e藥), a platform for customers to place orders online, make inquires and payment ,etc. In 2021, the Company ranked top 40 among top 100 PRC wholesalers, in respect of revenue generated from the principal business. The Company ranked the 6th among the pharmaceutical distribution businesses in Guangdong Province. 2022年,憑籍良好的信譽和優質服務,本公司獲得由藥鏈圈平台頒發的2021-2022年度醫藥冷鏈物流服務推薦企業(連續3年獲得),及2021-2022年度醫藥冷鏈最佳物流中心(基地)(連續4年獲得);本公司獲得由藥鏈圈認證中心頒發的2022年度醫藥物流配送優秀企業(連續2年獲得),及2022年度現代醫藥物流技術實驗基地(中心);獲得由中國In 2022, with its good reputation and excellent services, the Company was selected by the Pharmaceutical Chain Circle Platform as (for three consecutive years) a recommended pharmaceutical cold chain logistics services enterprise in 2021-2022 and as (for four consecutive years) the best logistics center (base) of pharmaceutical cold chain in 2021-2022; the Company was recognized by the Pharmaceutical Chain Circle Certification Center as (for two consecutive years) an excellent pharmaceutical logistics and distribution enterprise in 2022 and as a modern pharmaceutical logistics technology experimental -002- (廣州)國際物流裝備與技術展會組委會頒發的2021-2022年度中國物流行業金螞蟻創新獎(連續5年獲得),及連續十一年獲得由廣東省企業聯合會、廣東省企業家協會頒發的參加廣東省企業誠信興商工作證書;獲得由中國物流與採購聯合會醫藥物流分會頒發的2022年中國醫藥供應鏈銳意企業。 base (center) in 2022; (for five consecutive years) won the 2021-2022 Golden Ant Innovation Award for China’s Logistics Industry conferred by the Organizing Committee of China (Guangzhou) International Logistics Equipment and Technology Exhibition; and (for eleven consecutive years) received the certificate of participation in Guangdong enterprises' growing business in good faith conferred by Guangdong Provincial Federation of Enterprises and Guangdong Provincial Association of Entrepreneurs; Obtained the 2022 China Pharmaceutical Supply Chain Sharp Enterprise issued by the Pharmaceutical Logistics Branch of the China Federation of Logistics and Procurement. -003- 年度报告 ANNUAL REPORT 2022 公司資料 CORPORATE INFORMATION 4 主席報告 CHAIRMAN’S STATEMENT 7 財務摘要 FINANCIAL SUMMARY 11 管理層討論及分析 MANAGEMENT DISCUSSION AND ANALYSIS 12 董事、監事及高級管理人員履歷 BIOGRAPHIES OF DIRECTORS,SUPERVISORS AND SENIOR MANAGEMENT 35 企業管治報告 CORPORATE GOVERNANCE REPORT 44 董事會報告 DIRECTORS’ REPORT 71 監事會報告 BOARD OF SUPERVISORS’ REPORT 93 審計報告 AUDITOR’S REPORT 96 合併資產負債表 CONSOLIDATED BALANCE SHEET 103 母公司資產負債表 BALANCE SHEET OF THE PARENT COMPANY 107 合併利潤表 CONSOLIDATED INCOME STATEMENT 111 母公司利潤表 INCOME STATEMENT OF THE PARENT COMPANY 115 合併現金流量表 CONSOLIDATED STATEMENT OF CASH FLOW 117 母公司現金流量表 STATEMENT OF CASH FLOW OF THE PARENT COMP

你可能感兴趣

hot

创美药业2022中期报告

港股财报2022-09-23
hot

创美药业2020年报

港股财报2021-04-27
hot

创美药业2023年报

港股财报2024-04-26
hot

创美药业2021年报

港股财报2022-04-28